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Summary-The effects of i.v. administration of d9 THC, phencyclidine, the pyrrolidyl and 
piperidyl isomers of Ditran, and LSD-25 were determined on the spontaneous neocortical 
EEG and release of acetylcholine (ACh) from the somatosensory cortex of brainstem transected 
cats. dDTHC was given in doses of 05-l 1 mg/kg i.v. to animals with a pretrigeminal midpontine 
transection. de THC produced neocortical high voltage EEG slow waves which were more 
prominent in the frontal areas of the brain. At the same time, arterial blood pressure and 
heart rate were reduced slightly. These effects were observable in doses of 0.5 mg/kg, but were 
more obvious at larger doses. The administration of amphetamine promptly antagonized the 
EEG changes induced by A0 THC. In doses of 05 mg/kg, As THC caused either no effect or a 
slight increase in the release of ACh from the cortex. Larger doses caused a progressive decrease 
in ACh release. The effects of AD THC were antagonized by the administration of (+)-amphet- 
amine in doses of 2.5 mg/kg i.v. 
Phencyclidine in doses of 1 mg/kg iv. caused marked EEG changes consisting of high 
voltage, slow wave burst patterns, especially in the frontal cortex. At this dose, a slight increase 
in the cortical release of ACh was observed. Larger doses of 5 mg/kg which caused pronounced 
EEG changes did not significantly depress ACh release in contrast to pentobarbital(20 mg/kg) 
which dramatically reduced ACh release. 
Both isomers of Ditran caused EEG slowing in doses of 1 mg/kg and a dramatic increase 
in the release of ACh from the cortex. They produced about a 200% increase in ACh release. 
In contrast, LSD-25 had no marked effect on ACh release. The effects were much less obvious 
and depended upon basal release levels. If basal release was low to moderate, LSD-25 in doses 
of 0.1 mg/kg slightly increased ACh release, while larger doses caused no greater increase. If 
baseline release of ACh was high, the drug decreased release slightly. In such pretrigeminal 
midpontine transected cats, LSD-25 usually caused EEG high voltage, slow waves, and a 
decrease in arterial blood pressure. 
It is concluded that various hallucinogens differentially affect the neocortical release of 
ACh in pretrigeminal midpontine transected cats. A0 THC caused a definite decrease in ACh 
release similar to anesthetic agents like pentobarbital. A dissociative anesthetic such as phen- 
cyclidine produced negligible effects. The isomers of Ditran caused a marked increased release 
of ACh while LSD-25 had negligible effects. Gross EEG neocortical changes were not directly 
correlated with the cortical release of ACh per se. 
EXTENSIVE literature exists on the effects of various psychotropic drugs on the release of 
acetylcholine (ACh) from the cerebral cortex. Atropine and scopolamine (MITCHELL, 1963 ; 
SZERB, 1964; POLAK, 1965; BARTOLINI and PEPEU, 1967), (+)-amphetamine and (k)-DOPA 
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alone and in combination with imipramine (PEPEU and BARTOLINI, 1968), angiotensin 
(ELIE and PANISSET, 1970), nicotine (ARMITAGE, HALL and SELLERS, 1969) and pentylene- 
tetrazol (CELESIA and JASPER, 1966) all increase ACh release from the neocortex. Central 
nervous depressants such as pentobarbital (MACINTOSH and OBORIN, 1953; MITCHELL, 
1963; PEP~U and BARTOLINI, 1968), ethyl alcohol (GRAHAM and ERICKSON, 1971), narcotic 
analgesics such as morphine (BELESLIN and POLAK, 1965 ; BELESLIN, POLAK and SPROULL, 
1965; BEANI, BIANCHI, SANTINOCETO and MARCHETTI, 1968; SHARKAWI and SCHULMAN, 
1969) and ganglionic blockers such as hexamethonium (RAo, BHATT, GOPALAKRISHNA 
and HARANATH, 1970) decrease ACh release. 
In view of the fact that hallucinogenic substances may have interactions with central 
cholinergic mechanisms, it was decided to study their effects on the spontaneous release 
of ACh from the cat neocortex in I@IW. In view of the fact that the release of ACh varies 
with the level of excitation or depression of the activating system, it was decided to study 
EEG changes induced by the various drugs at the same time in midpontine pretrigeminal 
transected preparations. This manuscript describes the results obtained. 
METHODS 
Eighteen adult male cats weighing between 2.1 and 4.3 kg were used. All surgery was 
performed under halothane-air anesthesia. Suitable cannulae were inserted in the trachea, 
vein and artery for adequate ventilation, i.v. injections and for recording arterial blood 
pressure. The animal’s head was placed in a stereotaxic apparatus. The atlanto-occipital 
membrane was opened to allow free drainage of the cerebrospinal fluid. A stereotaxically 
oriented spatula was utilized for transections, which were made usually at the midpontine 
pretrigeminal level. Shortly following transection, the skull was opened over a large part of 
the frontoparietal and occipital areas. The cats were allowed to recover from the halothane 
anesthesia for 3 hr. During this interval they resumed spontaneous respiration. Body tem- 
perature was maintained as close to 37°C as possible as monitored by a rectal probe. Cats in 
which either brain hemorrhage or edema occurred were discarded. Blood pressure was 
recorded from the femoral artery by means of a Statham pressure transducer and a Grass 
polygraph. 
The collecting cups were constructed according to MITCHELL (1963). After opening the 
dura, a round Perspex cylinder covering0.76 cm% of the cortex was lowered onto the sensori- 
motor and its posterior association area with the aid of an adjustable electrode carrier. 
The cylinder was filled with O-7 ml of Ringer’s medium containing (concentration in g/l); 
NaCI, 9.0; KCl, O-42; CaCl,, 0.24; NaHCO,, 0.5; glucose, 1.0; and physostigmine sulphate, 
0.1. Every 10 min the solutions were aspirated from the collecting cups and immediately 
bioassayed for ACh using the dorsal muscle of the leech according to the method of 
MURNAGHAN (1958). The muscle was suspended in a 2 ml bath. The upper end of the muscle 
was connected to a small mirror which reflected a beam of light onto a graduated scale 
approximately 5 ft away on the wall allowing a 200-fold magnification. The samples collected 
from the cups were diluted with distilled water (1 volume diluted to 1.4 volumes) for the 
purpose of achieving isotonicity with leech Ringer solution. The samples were then compared 
with standard solutions of ACh HCI containing the same concentration of physostigmine. 
In order to assure that maximal cholinesterase inhibition had occurred in the area of the 
cortex beneath the cup, samples from the first three 10 min-intervals were not assayed. 
Evidence that the substance released into the cups was either ACh or some very similar 
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choline ester has been given previously (MITCHELL, 1963 ; SZERB, 1963 ; BARTOLINI and 
PEPEU, 1967). 
The electrical activity of the cortex was recorded by means of screw electrodes inserted 
into the skull and a silver ball electrode placed inside the collecting cup. 
In all experiments the drugs were injected through a polyethylene cannula inserted 
into the femoral vein. Following termination of the experiment, the brain was removed 
and the precise level of the brainstem transection was determined macroscopically. LSD-25 
and d 9 THC were obtained from the Center for Studies of Narcotic and Drug Abuse, FDA- 
NIMH Psychotomimetic Agents Advisory Committee through Dr. M. C. Braude, the 
Executive Secretary. The isomers of Ditran were obtained from Dr. Abood of the University 
of Rochester and phencyclidine from Dr. McCarthy of the Parke-Davis Company. 
RESULTS 
Baseline levels of spontaneous ACh release 
It is well known that the level of spontaneous release of ACh from the neocortex varies 
with the degree of anesthesia and level of brainstem transection. In order to assure a high 
level of spontaneous release, pretrigeminal brainstem transected preparations were used. 
Usually the mean of 3 assays before and after drug administration were obtained. In our 
animals the range in baseline release varied from a low of 8.0 to a high of 51.4 ng/cm2/10 min 
with a mean & S.E. for 24 animals before drug of22.9k2.2 ng/cm2/10 min 3 hr posthalothane 
anesthesia and brainstem transection. The factors involved in the wide range observed in 
baseline release of ACh probably include residual anesthesia and postsurgical brain trauma. 
Efsects of A9 THC 
A9 THC in doses of 0.5-l 1.0 mg/kg, i.v. produced high voltage slow waves in the EEG 
of the neocortex of pretrigeminal midpontine transected cats. These effects are illustrated 
in Figs. 1 and 2. EEG high voltage, slow waves were more prominent in the frontal than 
occipital cortical leads. The left frontal cortical lead which contained the bathing solution 
for collecting ACh showed EEG spikes and slow waves typical of the local effects of physo- 
stigmine. Small doses of As THC tended to exaggerate these effects, but in larger doses 
they were reduced (Fig. 2). The administration of (+)-amphetamine in doses of 2.5 mg/kg, 
i.v. dramatically antagonized most of the effects induced by A9 THC. 
As illustrated in Fig. 3 small doses of A9 THC in the order of 0.5 mg/kg produced 
variable effects on ACh release. Some animals showed a definite increase in ACh release, 
while others a slight decrease. However, larger doses of As THC produced consistent and 
progressively greater depression of ACh release. These effects are antagonized by (+-)- 
amphetamine. In a total of I1 animals studied the mean change in ACh release for 3 samples 
pre- and postdrug per dose was as follows: 
No. of animals 
3 0.5 mg/kg A9 THC+ 19 % 
2 1.0 mg/kg As THC- 9% 
2 1.5 mg/kg A9 THC- 7% 
1 3.5 mg/kg A9 THC-46 % 
2 6.0 mg/kg As THC-55 % 
1 11 *O mg/kg As THC-63 % 
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FIG. 1. EEG effects of As THC in the pretrigeminal midpontine transected cat. 
Neocortical EEG tracings are shown before and within a 4j hr after A* THC. In this and all 
subsequent figures, cats prepared under hdothane-air anesthesia and after brainstem trans- 
ection were allowed to breathe room air, Before drug administration the neocortical EEG 
shows desynchronization in the frontal and occipital leads except in the area (LF) over which 
the bathing cup containing artificial CSF with physostigmine was placed. Note the high voltage 
spikes in this area. After 1 mg/kg of A9 THC, generalized neocortical high voltage slow waves 
are observed occurring in burst-like fashion. They are more predominant in the frontal than 
occipital areas of the brain. Note that mean arterial blood pressure was reduced with a slight 
bradycardia. Symbols in this and subsequent figures are RF: right frontal somatosensory 
cortex, LF: left frontal somatosensory cortex, RO: right occipital and LO: left occipital cortex. 
Arterial blood pressure in mm Hg. 
Eflects ofphencyclidine 
The EEG effects of phencyclidine in pretrigeminal midpontine transected cats depend 
upon dosage. Small doses (1 mg/kg iv.) caused high voltage slow waves, especially prominent 
in the frontal areas of the brain (Fig. 4). Larger doses (5 mgfkg i.v.) produced spikes and 
suppression burst patterns throughout the neocortical EEG. In these doses phencyclidine 
had negligible effects on the release of ACh from the neocortex. In general, there was a 
tendency for a slight increase in release of ACh (Fig. 5). However, the effects were relatively 
slight and not statisticahy significant in contrast to the well known depressant effects of 
pentobarbital in an anesthetic dose. In a total of 4 animals studied the mean change in ACh 
release for 3 samples pre- and postdrug per animal for l-6 mg/kg of phencyclidine was a 
negligible +2.3 %, 
Efects of the isomers of Ditran 
The isomers of Ditran produced characteristic EEG slowing similar to that of other 
well known muscarinic choli~er~c antagonists which penetrate the bIood-brain barrier. 
Both the pyrrolidyl and piperidyl isomers produced an increase in spindle bursts in the 
neocortex following doses of 1 mg/kg i.v. A definite tachycardia also was observed (Fig. 6). 
Both isomers also caused a dramatic increase in neocortical ACh release well over 200% 
of control levels as can be seen in Fig. 7. The two isomers were equally effective in doses of 
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FIG. 2. Effects of do THC and (+)-amphetamine on the cat EEG. 
Monopolar EEG recordings are shown from the neocortex. The left frontal recording was taken 
from the surface of the cortex from which ACh was collected. Following the administration 
of physostigmine 1 x 1O-4 g/ml into the cup, local seizure activity was observed. Note that 
increasing doses of A8 THC progressively caused increased high voltage slow waves and reduced 
seizure discharge. These effects were promptly reversed by (+)-amphetamine. 
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FIG. 3. Effects of A9 THC and (+)-amphetamine on cortical release of acetylcholine. 
The height of each bar represents the release of ACh in ng/cms/10 min as noted on the ordinate. 
On the abscissa blocks of 10 min are given for 24 hr. Various drugs were injected at the arrows. 
Note that a large dose of A8 THC (3 mg/kg) reduced the release of ACh and that (+)-amphet- 
amine sulphate (2.5 mg/kg) antagonized this effect. 
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AFTER PHENCYCLIDINE (5mg/kq) AFTER PENTOBARBlTAL(20mg/kg) 
FIG. 4. EEG effects of phencyclidine in the pretrigeminal midpontine transected cats. 
Note the change in the neocortical EEG after 1 and 5 mg/kg iv. of phencyclidine. EEG record- 
ings were taken 5 min after injection. Marked high voltage slow wave activity is seen especially 
in the frontal areas after 1 mg/kg and the typical slow suppression fast wave bursts after 5 
mg/kg of phencyclidine. After 20 mg/kg of pentobarbital the EEG pattern changed to more 
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FIG. 5. Effect of phencyclidine on cortical release of acetylcholine. 
After 1 mg/kg of phencyclidine there was a negligible increase in neocortical release of ACh. 
Even an additional dose of 5 mg/kg of phencyclidine had insignificant effects. In contrast, 
pentobarbital (20 mg/kg iv.) caused a marked decrease in the cortical release of ACh. 
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FIG, 6. EEG changes induced by the pyrrolidyl isomer of Ditran in a pretrigeminai midpontine 
transected cat. 
Note that this drug in a dose of 1 mg/kg i.v. produced an increase in EEG slow waves in the 
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FIG. 7. Effects of the isomers of Ditran on the cortical release of acetylcholine in two different 
pretrigeminal midpontine transected cats. 
Note that foilowing 1 mg/kg of both isomers, there was a marked reiease of ACh for a con- 
siderable period of time. 
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1 mg/kg i.v., although complete dose-effect curves need to be determined for a precise 
comparison. In a total of 4 animals studied the mean change in ACh release after 1 mg/kg 
of the pyrrolidyl and piperidyl derivatives for 3 samples pre- and postdrug was an enormous 
+219*3 %. 
Eflects of LSD-25 
LSD-25 in doses of 0.1 and O-2 mg/kg in pretrigeminal midpontine transected cats 
tended to cause a decrease in mean arterial BP and an increase in neocortical slow waves 
(Fig. 8). This drug did not produce any dramatic changes in neocortical release of ACh 
in most of the animals studied. The effects seemed to be dependent in part upon baseline 
levels of ACh release. As illustrated in Fig. 9, if baseline level of ACh release was low, LSD-25 
in doses of 0.1 mg/kg produced a slight increase which lasted a relatively short time. Larger 
doses produced no greater increase. When baseline levels of ACh release were high, a dose of 
0.1 mg/kg tended to produce a transient decrease which lasted approximately 30 min. 
Larger doses (0.2 mg/kg) also tended to produce a gradual decrease in release as noted. 
The effects of LSD-25 on ACh release from the cat cerebral cortex were highly variable. 
As a result, in 5 animals studied in doses of 100-200 pg/kg the mean f S.E. ACh output in 
ng/cm2/10 min was 23.3f4.6 before and 22.6f3.4 after LSD-25, indicating no significant 
mean change. 
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FIG. 8. EEG effects of LSD-25 in the pretrigeminal midpontine transected cat. 
Note that after LSD-25 in a dose of 100 pg/kg the EEG did not become desynchronized as is 
true of intact preparations. Instead, some high voltage slow waves and spikes are seen in RF, 
RO and LO leads. There was also a fall in mean arterial BP. 
DISCUSSION 
One of the serious methodological limitations of research on the release of ACh from the 
neocortex into a collecting cup is the necessity of using a cholinesterase inhibitor to prevent 
ACh breakdown. The relatively high concentration of physostigmine used in this study 
(I.4 x 1O-4 M) caused local seizure activity as observed in the EEG. Thus the concentration 
Hallucinogens and ACh release 711 
40 
r 
LSb 25 LSd 25 
mg O.l/kg i.v. ma 0.2 /kg i.v. 
FIG. 9. Effect of LSD-25 on acetylcholine release in two different cat preparations with different 
basal output levels. 
The stippled bars represent ACh release from one cat and the open bars the other. Note that 
in the cat with high basal levels of ACh release, LSD-25 in a dose of 0.1 mg/kg caused a decrease 
in release which was relatively transient. This effect was enhanced by an additional dose of 
0.2 mg/kg iv. In contrast, in a cat with low basal output levels of ACh, the smaller doses of 
LSD-25 caused a transient increase in ACh release which was not reproduced by the larger 
dose. The important point is that the overall effects of LSD-25 are relatively slight. 
of cholinesterase inhibitor used was large enough to cause its own pharmacological effects. 
The leech muscle assay was controlled with standard solutions of acetylcholine containing 
the same concentration of physostigmine. However, it should be pointed out that the effect 
of any drug given systemically may be due to an interaction of the drug with physostigmine 
as well, or even instead of, a direct effect on the cholinergic mechanisms of the cat neocortex. 
It is, of course, necessary that future studies be undertaken using other cholinesterase 
inhibitors and especially varying their concentration such that prevention of ACh hydrolysis 
does not occur at the expense of local cortical seizures. 
The role of central cholinergic mechanisms in the action of various hallucinogenic 
substances is quite variable (GIARMAN and FREEDMAN, 1965; DOMINO, 1971; DOMINO and 
WILSON, 1972). In some cases, their interaction with central cholinergic mechanisms seems 
primary, while in others it appears to be a secondary or epiphenomenon. In general, most 
psychotropic drugs which produce EEG activation tend to increase neocortical ACh release, 
while those that produce EEG high voltage slow waves tend to decrease ACh release. How- 
ever, there are some dramatic exceptions. Centrally acting muscarinic cholinergic antagonists 
such as atropine and scopolamine are the best known exceptions in that they both cause 
EEG slow waves and a very large increase in ACh release. 
The effects of d g THC on both the neocortical EEG as well as the release of ACh reminds 
one of the actions of a central nervous system depressant with soporific-anesthetic properties. 
Increasing doses of this compound produced progressively greater EEG slow waves and a 
decrease in ACh release. It should be noted that in some preparations, small doses of this drug 
(O-5 mg/kg i.v.) produced a slight increase in neocortical release of ACh. This effect was not 
consistently seen, however. The finding that d g THC produces a decrease in release of cortical 
ACh is consistent with the findings of DOMINO (1972) and DOMINO and WILSON (1972) 
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that this drug elevates total brain ACh content similar to other sedative-soporific and 
narcotic drugs. It is of special interest that LAYMAN and MILTON (1971) have shown that both 
A9 THC and cannabidiol decrease the spontaneous release of ACh from guinea pig ileum 
and that these drugs act primarily at muscarinic cholinergic sites. 
In contrast, phencyclidine in doses up to 6 mg/kg i.v. produced no significant effects 
on the cortical release of ACh in spite of marked neocortical EEG changes. This dissociative 
anesthetic in non-anesthetizing doses in the rat may increase the utilization of ACh (DOMINO 
and WILSON, 1972). Nevertheless, in the cat this compound, in minimal anesthetizing doses, 
had no significant effect in contrast to central nervous system depressants such as pento- 
barbital and dg THC. It would appear that the mechanism of action of phencyclidine is 
completely different from other classes of central nervous system depressants. 
Both the pyrrolidyl and piperidyl isomers of Ditran were equally effective in causing 
EEG slow waves and a dramatic increase in the release of ACh from the cortex. These 
effects of Ditran are consistent with the known action of muscarinic cholinergic antagonists 
that can penetrate the blood-brain barrier. It is well known that atropine and scopolamine 
(MITCHELL, 1963 ; SZERB, 1964; POLAK, 1965 ; BARTOLINI and PEPEU, 1967) all cause a similar 
phenomenon. The present findings are consistent with the hypothesis that the central actions 
of Ditran involve antagonism of ACh. Of course other mechanisms have been implicated in 
the pharmacology of these substances (ABOOD, 1968). 
In contrast to the dramatic effects of the isomers of Ditran, LSD-25, in doses which alter 
the EEG, did not significantly affect neocortical release of ACh. It has been shown (DOMINO 
and WILSON, 1972) that large doses of LSD-25 may increase the brain utilization of ACh in 
rats. In the present experiment in cats, we did obtain marginal evidence that small doses of 
LSD-25 may cause a slight increase in the cortical release of ACh while larger doses tended 
to decrease its release. Especially clear is the fact that these changes are very slight and there- 
fore, do not in all probability relate to the primary mechanism of action of this drug. It is 
important to note that these experiments were conducted in acute cats with pretrigeminal 
midpontine transections in order to avoid the complicating features of general anesthesia. 
BRADLEY (1958) has emphasized the differential effects of (+)-amphetamine and LSD-25 
in the brainstem. His data suggest that (+)-amphetamine acts directly on the reticular 
formation of the brain while LSD-25 acts on the sensory input from the environment. 
He has pointed out that LSD-25 does not have any significant effect on the spontaneous 
activity of em&hale isok preparations where many afferents from the periphery are lacking. 
The well known EEG flattening and desynchronizing action of LSD-25 in the cat was not 
observed in our midpontine pretrigeminal transected cats. In contrast, LSD-25 usually 
produced a slight increase in amplitude and slowing of the EEG. However, KING KILLAM 
(1962) has been less impressed with the critical role of the brainstem in the action of this drug. 
In any event, it would seem that studies on cortical ACh release in unanesthetized animals 
with an intact brainstem are indicated. Our data would indicate that in brainstem transected 
cats LSD-25 has negligible effects in releasing neocortical ACh in contrast to the dramatic 
actions reported for (+)-amphetamine and DOPA (PEPEU and BARTOLINI, 1968). 
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